Skip to content
Screener

Veracyte VCYT Q1 2026 earnings

Reported May 5, 2026 · After market close

Revenue$139.1MBeat by $8.7M
EPS$0.52Beat by $0.18
Revenue estimate$130.4M
EPS estimate$0.34

Next report

Nov 3, 2026 (in 2 months)
Revenue estimate$147.2M
EPS estimate$0.43

Financials

Q1 2026

Income statement

See full
Revenue$139.1M+21.5%
Gross profit$101.2M+27.2%
Operating income$22.6M+680%
Net income$28.7M+307%
EPS (diluted)$0.35+289%

Balance sheet

See full
Cash & equivalents$264.8M+41.0%
Total debt$39.3M-22.1%
Total equity$1.3B+12.5%
Total assets$1.4B+9.2%

Cash flow

See full
Operating cash flow$35.2M+557%
CapEx$3.0M+62.8%
Free cash flow$32.3M+810%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$2.56B+10.7%
Enterprise value$2.33B+7.4%
P/E29.1×-40.8×
P/S4.7×-0.3×

Profitability

See full
Gross margin70.9%+2.9pp
Operating margin14.3%+9.2pp
Net margin16.2%+9.1pp
FCF margin28.7%+11.7pp

Returns & leverage

See full
Return on equity6.9%+4.1pp
Debt / equity0×0.0×
Current ratio9.3×+4.2×

Segments

By segment

See full
Reportable Segment$139.1M+21.5%

By product

See full
Testing revenue$135.1M+25.9%

FAQ

When did Veracyte report Q1 2026 earnings?
Veracyte (VCYT) reported Q1 2026 earnings on May 5, 2026 after market close.
What were Veracyte's Q1 2026 revenue and EPS?
Veracyte reported revenue of $139.1M and eps of $0.52 for Q1 2026.
Did Veracyte beat estimates in Q1 2026?
Revenue beat the consensus estimate of $130.4M by $8.7M. EPS beat the consensus estimate of $0.34 by $0.18.
How did Veracyte's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 21.5% from $114.5M a year earlier and eps grew 67.7% from $0.31.
Where can I find Veracyte's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001384101-26-000029) and the 10-Q periodic report (0001384101-26-000031) directly on SEC EDGAR. The filing index links above go to sec.gov.